Turkiye Klinikleri Journal of Forensic Medicine and Forensic Sciences

.: REVIEW
Türkiye'de Yeni Nesil Psikoaktif Maddeler Gerçeği: 2013'ten Günümüze Yaşanan Değişimler: Sistematik Derleme
The Fact of New Generation Psychoactive Substances in Türkiye: Changes since 2013: Systematic Review
Asena AVCI AKCAa,e, Nebile DAĞLIOĞLUa,d, Berfin Sude ERTAŞa , Şafak YALÇIN ŞAHİNERb,d, Necdet ÜNÜVARc
aAnkara Üniversitesi Adli Bilimler Enstitüsü, Adli Toksikoloji AD, Ankara, Türkiye
bAnkara Üniversitesi Tıp Fakültesi, Ruh Sağlığı ve Hastalıkları AD, Ankara, Türkiye
cAnkara Üniversitesi Rektörlüğü, Ankara, Türkiye
dAnkara Üniversitesi Bağımlılıkla Mücadele Uygulama ve Araştırma Merkezi, Ankara, Türkiye
eAkdeniz Üniversitesi Fen Fakültesi, Biyoloji Bölümü, Antalya, Türkiye
Turkiye Klinikleri J Foren Sci Leg Med. 2025;22(1):45-59
doi: 10.5336/forensic.2024-104914
Article Language: TR
Full Text
ÖZET
 Bu çalışma, Türkiye'de yeni nesil psikoaktif maddelerin (NPS) kullanımında son 10 yılda yaşanan değişimleri incelemekte ve bu maddelerin halk sağlığına yönelik oluşturduğu tehditlere odaklanmaktadır. NPS'ler, mevcut yasal düzenlemelerin kontrol alanı dışında kalan, ancak halk sağlığı ve güvenliği için ciddi riskler teşkil eden maddelerdir. NPS'ler, özellikle toksisite seviyelerinin bilinmezliği ve hızla değişen yapıları nedeniyle hem tespiti hem de kontrol altına alınması zor olan maddeler arasında yer almaktadır. Türkiye'de NPS ile mücadelede ulusal ve uluslararası düzeyde çeşitli stratejiler uygulanmakta olup, bu maddelerin tespiti, izlenmesi ve kontrol altına alınması amacıyla Avrupa Birliği Uyuşturucu Ajansı ve Türkiye Uyuşturucu ve Uyuşturucu Bağımlılığı İzleme Merkezi gibi kurumlar önemli roller üstlenmektedir. Son yıllarda özellikle ''Bonzai'' gibi sentetik kannabinoidler Türkiye'de yaygın olarak kullanılmış ve ciddi sağlık sorunlarına yol açmıştır. Çalışma, Türkiye'de NPS ile mücadelede yasal düzenlemelerdeki gelişmeleri ele almakta, bu süreçte ulusal mevzuatın sıkılaştırılması ve kurumlar arası işbirliğinin artırılmasına dair öneriler sunmaktadır. Ayrıca, koronavirüs hastalığı-2019 pandemisinin NPS kullanımı üzerindeki etkileri analiz edilmekte ve pandeminin getirdiği sosyal değişimlerin madde kullanım eğilimlerini nasıl etkilediği irdelenmektedir. Türkiye'de NPS ile ilgili tedavi hizmetleri ve bağımlılık alanındaki gelişmeler de bu çalışmanın önemli bir parçasını oluşturmaktadır. Sonuç olarak, Türkiye'de NPS kullanımı ile mücadelede elde edilen deneyimlerin ve uygulanan stratejilerin, gelecekteki politikaların şekillendirilmesine önemli katkılar sunacağı düşünülmektedir. Bu çalışma, Türkiye'deki NPS ile mücadeleye yönelik geniş kapsamlı bir değerlendirme sunarak, halk sağlığını koruma yönündeki politikaların geliştirilmesine ışık tutmayı amaçlamaktadır.

Anahtar Kelimeler: Yeni psikoaktif maddeler; halk sağlığı ve güvenliği; uyuşturucu politikası; adli toksikoloji; düzenlemeler
ABSTRACT
 This study examines the changes in the use of new psychoactive substances (NPS) in Türkiye over the past decade, focusing on the public health threats posed by these substances. NPS are substances that fall outside the scope of current legal regulations but pose serious risks to public health and safety. Due to the unknown toxicity levels and rapidly evolving structures of NPS, they are challenging to detect and control. Various national and international strategies are implemented in Türkiye to combat NPS, with institutions such as the European Union Drugs Agency and the Turkish Monitoring Centre for Drugs and Drug Addiction playing key roles in detecting, monitoring, and controlling these substances. In recent years, synthetic cannabinoids like ''Bonzai'' have become prevalent in Türkiye, leading to serious health issues. This study addresses developments in legal regulations in Türkiye's fight against NPS, offering recommendations for tightening national legislation and enhancing inter-agency cooperation. Additionally, the impact of the coronavirus disease-2019 pandemic on NPS use is analyzed, exploring how social changes brought about by the pandemic have influenced substance use trends. Treatment services and advancements in addiction care related to NPS in Türkiye are also integral parts of this study. In conclusion, it is anticipated that the experiences gained and strategies implemented in Türkiye's struggle with NPS will significantly contribute to shaping future policies. By providing a comprehensive assessment of efforts against NPS in Türkiye, this study aims to guide the development of policies aimed at protecting public health.

Keywords: New psychoactive substances; public health and safety; drug policy; forensic toxicology; regulations
REFERENCES:
  1. Chepyala D, Tsai IL, Liao HW, Chen GY, Chao HC, Kuo CH. Sensitive screening of abused drugs in dried blood samples using ultra-high-performance liquid chromatography-ion booster-quadrupole time-of-flight mass spectrometry. J Chromatogr A. 2017;1491:57-66. [Crossref]  [PubMed] 
  2. UNODC [Internet]. What are NPS? © 2025 UNODC [Cited: 15 September 2024] Available from: [Link] 
  3. Baumeister D, Tojo LM, Tracy DK. Legal highs: staying on top of the flood of novel psychoactive substances. Ther Adv Psychopharmacol. 2015;5(2):97-132. [Crossref]  [PubMed]  [PMC] 
  4. Omar J, Slowikowski B, Guillou C, Reniero F, Holland M, Boix A. Identification of new psychoactive substances (NPS) by Raman spectroscopy. J Raman Spectrosc. 2019;50(1):41-51. [Crossref] 
  5. Zloh M, Samaras EG, Calvo-Castro J, Guirguis A, Stair JL, Kirton SB. Drowning in diversity? A systematic way of clustering and selecting a representative set of new psychoactive substances. RSC Adv. 2017;7(84):53181-91. [Crossref] 
  6. Strehmel N, Vejmelka E, Kastner K, Roscher S, Tsokos M, Scholtis S. NPS-findings in forensic toxicology - three case reports. Toxichem Krimtech. 2017;84(3):199-204. [Link] 
  7. Simão AY, Antunes M, Cabral E, Oliveira P, Rosendo LM, Brinca AT, et al. An update on the implications of new psychoactive substances in public health. Int J Environ Res Public Health. 2022;19(8):4869. [Crossref]  [PubMed]  [PMC] 
  8. TUBİM. 2023 Türkiye Uyuşturucu Raporu. 1. Baskı. Ankara: NDB Yayınları; 2023. [Link] 
  9. TUBİM. 2022 Türkiye Uyuşturucu Raporu. 1. Baskı. Ankara: NDB Yayınları; 2022. [Link] 
  10. Yeter O, Erol Öztürk Y. Yasal & Yasadışı Maddeler ve Adli Toksikolojik Yaklaşımlar. Akgür SA, editör. 1. Baskı. Ankara: Akademisyen Kitabevi; 2021. [Crossref] 
  11. Mounteney J, Griffiths P, Sedefov R, Noor A, Vicente J, Simon R. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction. 2016;111(1):34-48. [Crossref]  [PubMed] 
  12. Mercolini L, Protti M. Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis. J Pharm Biomed Anal. 2016;130:202-19. [Crossref]  [PubMed] 
  13. EMCDDA. EMCDDA operating guidelines for the European Union-Early Warning System on new psychoactive substances. 2019;2006(1920):1-27. [Link] 
  14. UNODC. Special Segment - synthetic cannabinoids: Key facts about the largest and most dynamic group of NPS. Global SMART Updates. 2015;13:1-12. [Link] 
  15. UNODC [Internet]. World Drug Report 2023. © 2023 UNODC [Cited: June 23, 2024] Availablefrom: [Link] 
  16. Kaçakçılık ve Organize Suçlarla Mücadele Daire Başkanlığı. Kaçakçılık ve Organize Suçlarla Mücadele 2012 Raporu. Ankara: KOM Yayınları; 2013. [Link] 
  17. Atasoy A, Daglioglu N, Gören İE, Girisbay A, Aslan R, Akgur SA. Determination of synthetic cannabinoids in randomly urine samples collected from probationers in Turkey. Forensic Sci Int. 2021;322:110752. [Crossref]  [PubMed] 
  18. Drug Enforcement Administration. Fentanyl - Get Smart About Drugs. 2022. [Link] 
  19. Stanley TH, Egan TD, Van Aken H. A tribute to Dr. Paul A. J. Janssen: entrepreneur extraordinaire, innovative scientist, and significant contributor to anesthesiology. Anesth Analg. 2008;106(2):451-62, table of contents. [Crossref]  [PubMed] 
  20. Angelini DJ, Biggs TD, Prugh AM, Smith JA, Hanburger JA, Llano B, et al. Detection of fentanyl and derivatives using a lateral flow immunoassay. Forensic Chemistry. 2021;23:100309. [Crossref] 
  21. Schüller M, Lucic I, Øiestad ÅML, Pedersen-Bjergaard S, Øiestad EL. High-throughput quantification of emerging "nitazene" benzimidazole opioid analogs by microextraction and UHPLC-MS-MS. J Anal Toxicol. 2023;47(9):787-96. [Crossref]  [PubMed]  [PMC] 
  22. Walton SE, Krotulski AJ, Logan BK. A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LCQQQ-MS). J Anal Toxicol. 2022;46(3):221-31. [Crossref]  [PubMed]  [PMC] 
  23. Pergolizzi J Jr, Raffa R, LeQuang JAK, Breve F, Varrassi G. Old drugs and new challenges: a narrative review of nitazenes. Cureus. 2023;15(6):e40736. [Crossref]  [PubMed]  [PMC] 
  24. Teker C, Aslan R, İpekçi C, Tokdemir M, Akgür SA. Pregabalin qualitative detection in turkish forensic cases between 2017 to 2018. J Psychoactive Drugs. 2024;56(3):380-6. [Crossref]  [PubMed] 
  25. Evoy KE, Morrison MD, Saklad SR. Abuse and misuse of pregabalin and gabapentin. Drugs. 2017;77(4):403-26. [Crossref]  [PubMed] 
  26. Langlumé L, Eiden C, Roy S, Taruffi F, Gambier J, Donnadieu-Rigole H, et al. Management of pregabalin use disorder: a case series. J Psychoactive Drugs. 2022;54(4):386-91. [Crossref]  [PubMed] 
  27. TUBİM. 2021 Türkiye Uyuşturucu Raporu. 1. Baskı. Ankara: NDB Yayınları; 2021. [Link] 
  28. EMCDDA [Internet]. Methamphetamine in Europe EMCDDA-Europol threat assessment. 2019. Available from: [Link] 
  29. TUBİM. Metamfetamin; Türkiye ve Dünyadaki Durumu. 1. Baskı. Ankara: NDB Yayınları; 2022. [Link] 
  30. Back S, Kroon E, Colyer-Patel K, Cousijn J. Does nitrous oxide addiction exist? An evaluation of the evidence for the presence and prevalence of substance use disorder symptoms in recreational nitrous oxide users. Addiction. 2024;119(4):609-18. [Crossref]  [PubMed] 
  31. EMCDDA. Recreational Use of Nitrous Oxide: A Growing Concern for Europe. 2022. [Crossref] 
  32. European Union Drugs Agency. No laughing matter-new report shows rise in recreational use of nitrous oxide. European Monitoring Centre For Drugs And Drug Addiction. 2022. [Link] 
  33. Centola C, Giorgetti A, Zaami S, Giorgetti R. Effects of GHB on psychomotor and driving performance. Curr Drug Metab. 2018;19(13):1065-72. [Crossref]  [PubMed] 
  34. Busardò FP, Jones AW. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Curr Neuropharmacol. 2015;13(1):47-70. [Crossref]  [PubMed]  [PMC] 
  35. Brennan R, Van Hout MC. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups. J Psychoactive Drugs. 2014;46(3):243-51. [Crossref]  [PubMed] 
  36. EMCDDA [Internet]. European Drug Report 2022: Trends and Developments.© 2022 European Monitoring Centre for Drugs and Drug Addiction. [Cited: May 5, 2024]Available from: [Link] 
  37. Ünver Y. Maddeler ile ilgili yasal düzenlemeler. Akgür SA editör. Yasal&Yasadışı Maddeler ve Adli Toksikolojik Yaklaşımlar. 1. Baskı. Ankara: Akademisyen Kitabevi; 2021:41-62.
  38. Resmî Gazete (05.04.2023/32154) 7445 sayılı İcra Ve İflas Kanunu İle Bazı Kanunlarda Değişiklik Yapılmasına Dair Kanun; 2023.
  39. Resmî Gazete (17.4.2015, Sayı: 29329) sayılı Karayolları Trafik Yönetmeliğinde Değişiklik Yapılmasına Dair Yönetmelik; 2015.
  40. Resmî Gazete (2.12.2016/29906) 6763 sayılı Ceza Muhakemesi Kanunu İle Bazı Kanunlarda Değişiklik Yapılmasına Dair Kanun; 2016.
  41. Resmî Gazete (05.04.2023/32154) 7442 sayılı Orman Kanunu Ve Bazı Kanunlarda Değişiklik Yapılmasına Dair Kanun.; 2023.
  42. TUBİM. 2019 Türkiye Uyuşturucu Raporu. Ankara; 2019. [Link] 
  43. TUBİM. 2013 Türkiye Uyuşturucu Raporu (2012 Verileri) Reitox Ulusal Temas Noktası. 2013. [Link] 
  44. TUBİM. 2020 Türkiye Uyuşturucu Raporu. 1. Baskı. Ankara: NDB Yayınları; 2020. [Link] 
  45. TUBİM. 2018 Türkiye Uyuşturucu Raporu. 2018. [Link] 
  46. TUBİM. 2017 Türkiye Uyuşturucu Raporu (2016 Verileri) Reitox Ulusal Temas Noktası. 2017. [Link] 
  47. TUBİM. 2016 Türkiye Uyuşturucu Raporu (2015 Verileri). 2016. [Link] 
  48. TUBİM. 2015 Türkiye Uyuşturucu Raporu (2014 Verileri). 2015. [Link] 
  49. TUBİM. 2014 Türkiye Uyuşturucu Raporu (2013 Verileri) Reitox Ulusal Temas Noktası. 2014 [Link] 
  50. Avrupa Uyuşturucu ve Uyuşturucu Bağımlılığı İzleme Merkezi. Avrupa Uyuşturucu Raporu: Temel Sorunlar 2020. Lüksemburg: Avrupa Birliği Resmi Yayın Ofisi; 2020. [Link] 
  51. Barefoot RR, Byrne RH, Buffle J, Davidson CM, Evans LJ, Filella M. Trends and Developments. In: Barefoot RR ed. Chemical Speciationin the Environment. ed. Wiley Online Books; 2021. p. 401-31. [Crossref] 
  52. Engel BS. Trends and Developments. Trusts & Trustees. 2020;3(1):3. [Crossref] 
  53. Öztürk YE, Yeter O, Ateş I. Changes in the frequency and pattern of drugs detected among suspected drug users during the COVID-19 pandemic in Turkey. Int J Legal Med. 2022;136(5):1273-9. [Crossref]  [PubMed]  [PMC] 
  54. Aydoğdu M, Aslan R, Can Ö, Altunci YA, Annette Akgür S. Evaluation of substance use in Izmir during the COVID-19 pandemic. J Subst Use. 2022;27(6):629-35. [Crossref] 
  55. Eroğlu İçli H editör. Alkol ve madde analizlerinde tarama yöntemleri, preanalitik-analitik-postanalitik süreç, mevzuat. 22. Ulusal Klinik Biyokimya Kongresi 12-15 Mayıs 2022. Yuvarlak MasaToplantıları Madde Bağımlılığı. Antalya: 2022:103-5. [Link] 
  56. AKTOD. Adli Toksikoloji Laboratuvar Rehberi. Akgür SA, Dağlıoğlu N, editörler. Temel Adli Toksikoloji. 1. Baskı. Ankara: Akademisyen Kitabevi; 2018. p.1-21.
  57. Kume T, Karakukcu C, Kara Uzun N, Pınar A. Tıbbi laboratuvarlarda madde analizleri [Drug abuse testing in clinical laboratories]. Türk Klin Biyokim Derg. 2016;14(1):58-71. [Link] 
  58. T.C. Adalet Bakanlığı Adli Tıp Kurumu [İnternet]. Yeni Nesil Psikoaktif Maddeleri Tanımlamak İçin Sonuna Kadar Mücadele Ediyoruz. [Erişim tarihi: 17 Ekim 2024]. Haberler. Erişim linki: [Link] 
  59. T.C. İçişleri Bakanlığı Emniyet Genel Müdürlüğü Kriminal Daire Başkanlığı. Bölge Kriminal Polis Laboratuvarı Müdürlükleri Yönetmeliği. [Link] 
  60. T.C. İçişleri Bakanlığı Jandarma Genel Komutanlığı Kriminal Başkanlığı. Ankara Jandarma Kriminal Laboratuvar Müdürlüğü. [Link] 
  61. Ankara Üniversitesi Adli Bilimler Enstitüsü. Labaratuvar Hizmetleri. [Link] 
  62. Hacettepe Üniversitesi Tıp Fakültesi Adli Tıp Anabilim Dalı. Toksikoloji Laboratuvarı. [Link] 
  63. İstanbul Üniversitesi-Cerrahpaşa Adli Tıp ve Adli Bilimler Enstitüsü. Adli Bilimler Laboratuvarı. [Link] 
  64. Emniyet Genel Müdürlüğü Narkotik Suçlarla Mücadele Başkanlığı [İnternet]. Narkotik Suçlarla Mücadele Eğitim Akademisi. © 2025 Emniyet Genel Müdürlüğü Narkotik Suçlarla Mücadele Başkanlığı [Erişim tarihi: 10 Şubat 2025]. Erişim linki: [Link] 
  65. Vaccaro G, Massariol A, Guirguis A, Kirton SB, Stair JL. NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches. Drug Test Anal. 2022;14(8):1350-67. [Crossref]  [PubMed]  [PMC] 
  66. Topçuoğlu T. Ceza infaz kurumlarında gerçekleştirilen madde bağımlılığı programlarının etkinliği: meta-analiz çalışmaların sistematik olarak incelenmesi. Addicta Turkish J Addict. 2016;3(1):87-124. [Crossref] 
  67. Bilgener E, Gümüş B. Pregabalin consumption in Turkey: was it an abuse? Farmacia. 2021;69(6):1189-94. [Crossref] 
  68. Akca AA, Couchman L, Frinculescu A, Johnston A. Analysis of drug-impregnated paper samples seized in English prisons between 2018 and 2020. Forensic Sci Int. 2024;357:111991. [Crossref]  [PubMed] 
  69. Volkow ND, Blanco C. Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023;22(2):203-29. [Crossref]  [PubMed]  [PMC] 
  70. Resmî Gazete (10.03.2019, Sayı: 30710) sayılı Bağımlılık Danışma, Arındırma ve Rehabilitasyon Merkezleri Hakkında Yönetmelik; 2019. [Link] 
  71. Bestepe EE, Tunali N, Sarıdoğan GE. Sexual adverse effects and erectile dysfunction during buprenorphine/naloxone combination treatment for opioid use disorders. Neuropsychiatr Dis Treat. 2020;16:2695-705. [Crossref]  [PubMed]  [PMC] 
  72. Meclis Araştırması Komisyonu (MAK). Uyuşturucu Başta Olmak Üzere Madde Bağımlılığı ve Kaçakçılığı Sorunlarının Araştırılarak Alınması Gereken Önlemlerin Belirlenmesi Amacıyla Kurulan Meclis Araştırması Komisyonu Raporu. Türkiye Büyük Millet Meclisi Yayınları; 2008. [Link] 
  73. TUBİM. Ulusal Uyuşturucu ile Mücadele Eylem Planı 2016-2018. [Link] 
  74. Resmî Gazete (14.02.2019, Sayı: 30686) 2019/2 sayılı Cumhurbaşkanlığı Genelgesi; 2019. [Link] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com